Icahn School of Medicine, Mount Sinai, New York, New York, USA
Department of Medicine, Mount Sinai, New York, New York, USA.
BMJ Open Qual. 2023 Mar;12(1). doi: 10.1136/bmjoq-2022-002128.
Over-ordering of daily laboratory tests adversely affects patient care through hospital-acquired anaemia, patient discomfort, burden on front-line staff and unnecessary downstream testing. This remains a prevalent issue despite the 2013 Choosing Wisely recommendation to minimise unnecessary daily labs. We conducted a systematic review of the literature to identify interventions targeting unnecessary laboratory testing.
We systematically searched MEDLINE, EMBASE, Cochrane Central and SCOPUS databases to identify interventions focused on reducing daily complete blood count, complete metabolic panel and basic metabolic panel labs. We defined interventions as 'effective' if a statistically significant reduction was attained and 'highly effective' if a reduction of ≥25% was attained.
The search yielded 5646 studies with 41 articles that met inclusion criteria. We grouped interventions into one or more categories: audit and feedback, cost display, education, electronic medical record (EMR) change, and policy change. Most interventions lasted less than a year and used a multipronged approach. All five strategies were effective in most studies with EMR change being the most commonly used independent strategy. EMR change and policy change were the strategies most frequently reported as effective. EMR change was the strategy most frequently reported as highly effective.
Our analysis identified five categories of interventions targeting daily laboratory testing. All categories were effective in most studies, with EMR change being most frequently highly effective.
CRD42021254076.
过度订购日常实验室检测会通过医院获得性贫血、患者不适、一线工作人员负担和不必要的下游检测对患者护理产生不利影响。尽管 2013 年“明智选择”建议尽量减少不必要的日常实验室检测,但这仍然是一个普遍存在的问题。我们对文献进行了系统评价,以确定针对不必要的实验室检测的干预措施。
我们系统地搜索了 MEDLINE、EMBASE、Cochrane 中心和 SCOPUS 数据库,以确定专注于减少每日全血细胞计数、全面代谢谱和基本代谢谱实验室检测的干预措施。如果达到统计学显著降低,则将干预措施定义为“有效”,如果降低≥25%,则将干预措施定义为“高度有效”。
搜索结果产生了 5646 项研究,其中有 41 篇文章符合纳入标准。我们将干预措施分为一个或多个类别:审计和反馈、成本展示、教育、电子病历 (EMR) 更改和政策更改。大多数干预措施持续时间不到一年,并采用了多管齐下的方法。所有五种策略在大多数研究中都是有效的,其中 EMR 更改是最常用的独立策略。EMR 更改和政策更改是最常被报道为有效的策略。EMR 更改是最常被报道为高度有效的策略。
我们的分析确定了针对日常实验室检测的五类干预措施。所有类别在大多数研究中都是有效的,其中 EMR 更改是最常被报道为高度有效的策略。
PROSPERO 注册号:CRD42021254076。